We found in the current hyperglycemic stroke experiment that pregabalin has potent anti-inflammatory properties via downregulation of the HMGB1/TLR-4 signaling pathway and attenuation of p-NF-κB expression. The gene discussed is TLR4; the disease is stroke disorder.